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A b s t r a c t
Objective: To study the density and cross-sectional area of axons in the optic nerve in elderly control subjects and in
cases of Alzheimer’s disease (AD) using an image analysis system. 
Methods: Sections of optic nerves from control and AD patients were stained with toluidine blue to reveal axon profiles. 
Results: The density of axons was reduced in both the center and peripheral portions of the optic nerve in AD
compared with control patients. Analysis of axons with different cross-sectional areas suggested a specific loss of the
smaller sized axons in AD, i.e., those with areas less that 1.99 µm2. An analysis of axons >11 µm2 in cross-sectional
area suggested no specific loss of the larger axons in this group of patients. 
Conclusions: The data suggest that image analysis provides an accurate and reproducible method of quantifying
axons in the optic nerve. In addition, the data suggest that axons are lost throughout the optic nerve with a specific
loss of the smaller-sized axons. Loss of the smaller axons may explain the deficits in color vision observed in
a significant proportion of patients with AD. 
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Introduction
Alzheimer’s disease (AD) is a neurodegenerative
disorder of the central nervous system affecting
approximately 1 in 10 of the population aged 65 or
over. Disturbances of short-term memory, judgement,
and emotion are characteristic of such patients.
Patients with AD also exhibit a variety of ocular and
visual problems [4] including abnormalities of color
vision [7,8,20], eye movement [11,12,20,24], contrast
sensitivity [23], motion perception, and complex visual
functions such as reading and object recognition [7]. 
To attempt to explain the visual symptoms of
patients with AD, pathological studies have been
carried out on the retina [15], optic nerve [15], and
visual cortex [2,3]. Gliosis, demyelination and
increased densities of corpora amylacea have all
been reported in optic nerves of elderly control
subjects [13]. In addition, axon counts in the optic
nerve decrease with age [10,16-18,21] with swelling
and shrinking of individual axons [14]. In AD, the
demonstration of axon loss in the optic nerve has
been controversial. Some studies [15,25] have
reported a loss of the larger-diameter axons while
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other studies have suggested that myelinated axons
are unaffected [9]. 
The present study quantified axon densities and
cross-sectional areas in the optic nerve using an
image analysis system and had the following
objectives: 1) to determine the reproducibility of axon
counts made by an image analysis system compared
with manual counts, 2) to compare axon densities in
the center and periphery of the optic nerve in AD
patients with non-demented elderly controls, and 3)
to determine whether there was a preferential loss of
the larger or smaller-sized axons in the central and
peripheral regions of the nerve. 
Materials and methods
Cases
Optic nerves from AD cases were obtained from
the Brain Bank, Dept. of Neuropathology, Institute of
Psychiatry, London, UK while optic nerves from
non-demented elderly control cases were obtained
from the Institute of Psychiatry and from the
University of Birmingham Medical School (Table 1).
Informed consent was given for the removal of all
brain tissue according to the Declaration of Helsinki
(1964). The control cases (n=13) had no neurological
or psychiatric histories and were matched to the AD
cases as closely as possible for gender and age.
Post-mortem delay was less than 20 hours in each
case. The AD cases (n=12) were clinically assessed
and all fulfilled the ‘National Institute of
Neurological and Communicative Disorders and
Stroke and Alzheimer’s Disease and Related
Disorders Association’ (NINCDS/ADRDA) criteria for
probable AD [27]. The histological diagnosis of AD
was established by the presence of widespread
neocortical senile plaques (SP) consistent with the
‘Consortium to Establish a Registry of Alzheimer’s
Disease’ (CERAD) criteria [22]. 
Histological methods
From each patient, a segment of the optic nerve
was removed 4-5 mm in front of the optic chiasm.
Tissue was embedded in epoxy-resin and 1-2 µm
coronal sections cut and stained with toluidine blue
to reveal the axon profiles. 
Morphometric methods
The density and cross-sectional area of axons in
the tissue sections were quantified using an image
analysis system [26]. This system comprised a Carl
Zeiss Photomicroscope fitted with a Hatachi Saticon
color camera. The microscope was connected to an
Apple Macintosh IIci computer. Computer images were
analyzed using ‘Image’ software developed by NIH,
Bethesda, USA (Available from: National Technical
Information Service, Springfield, Virginia, USA; Part
number: PB93-504868). Each section of the optic nerve
was divided into four approximately equal quadrants.
Two sample fields, each 1971 µm2 in area were located
within each quadrant, one as close as possible to the
edge and the other to the center of the section. The
image of each field was captured (Fig. 1A), a smoothing
filter was applied and the contrast enhanced. Each
axon was then outlined manually on the screen (Fig.
1B). A screen magnification of x8 was used to aid
identification of axon profiles. Ambiguous structures
were excluded at this stage and the outlines of the
axons emphasized. The number of axons present in
the field was counted and the myelinated
cross-sectional area of each axon measured.
Cross-sectional areas were quantified rather than
diameters because axon profiles are commonly
asymmetrical in shape. The size measurements of
axons in the optic nerve were assigned to a number of
area classes (0-0.99, 1-1.99, 2-2.99 µm2 etc., up to
a maximum area class of >11 µm2). 
Patient group N Sex ratio Mean age SD Age range
(M:F) (years) (years)
non-demented elderly 13 6:7 78.5 8.57 66-82
Alzheimer’s disease 12 5:7 81.9 6.54 69-84
Table 1. Details of patients used in the study
N = number of patients, M = male, F = female, SD = standard deviation
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Reproducibility of axon counts
To compare the reproducibility of axon counts
made manually and by the image analysis system,
ten microscopic fields were photographed at
a magnification of x100 and then captured using the
image analysis system. Duplicate counts of the
numbers of axons were made manually from the
photomicrographs and from the image analysis
system. The reproducibility of the duplicate counts
both within and between methods were analyzed
using the intra-class correlation coefficient [5]. 
Analysis of axon counts 
and cross-sectional areas
The data were analyzed using analysis of variance
(ANOVA) (SuperANOVA Software, Abacus Concepts
Inc., Berkeley, CA 1989, USA). First, the density of axons
per sample field in the center and periphery of the
optic nerve in control and AD patients was analyzed by
a two-factor, split-plot ANOVA with patient group as
the major factor and region of the optic nerve as the
subplot factor. Second, axons of different
cross-sectional area were analyzed by a three-factor,
split-split plot ANOVA with patient group as the major
factor, area class of axons and location within the nerve
being the subplot factors. Third, axons with larger
cross-sectional areas (>11 µm2) in the center and
periphery of the nerve were analyzed separately using
a two-factor, split-plot ANOVA with patient group as the
major factor and size of axons as the subplot factor. 
Results
The reproducibility of axon counts made manually
and by image analysis is shown in Table 2. Image
analysis counts (rI=0.99) were considerably more
reproducible than manual counts (rI=0.28). In
addition, agreement between sets of counts
obtained by both methods varied considerably from
image to image (r=0.70), 5/10 images showing good
agreement and 5/10 poor agreement. 
Axon counts made in the central and peripheral
portions of the nerve in AD and elderly control
subjects are shown in Fig 2. There was a reduction in
Fig. 1. Image analysis of axon profiles in a section
of the optic nerve: A) Capturing the image on
computer screen, B) Outlining the axons prior to
measuring and counting. Magnification bar 5 µm
Fig. 2. Mean number of axons in the center and
periphery of the optic nerve in elderly control
subjects and patients with Alzheimer’s disease.
ANOVA: Patient group F=9.64 (P<0.01), Location
F=11.84 (P<0.01), Interaction F=1.13 (P>0.05) 
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axon counts in AD compared with elderly controls in
the center and periphery of the nerve (F=9.64, P<0.01),
the non-significant interaction (F=1.13, P>0.05)
suggesting losses were similar in both portions of the
nerve. Analysis of portions of nerve corresponding to
the nasal and temporal visual fields of the retina also
revealed similar losses of axons. 
Mean counts of axons of different cross-sectional
area per sample field are shown in Fig. 3. These data
suggest a specific loss of the smaller sized axons in
the center and periphery of the nerve, i.e., those with
cross-sectional areas <1.99 µm2. In addition, axons of
larger cross-sectional area (>11 µm2) were analyzed
separately (Fig. 4). These data suggest a greater
proportion of larger sized axons at the periphery of
the nerve compared with the center. However, no
significant difference in the proportions of large
axons was observed in the center or periphery of the
nerve in AD compared with controls. 
Discussion
Estimation of axon densities may be influenced by
a number of factors including age, gender, post-mortem
delay, time to fixation, the image analysis system used,
and the criteria employed to select or reject axon
profiles. In the present study, patient groups were
matched as closely as possible for age and sex. In
Manual Image analysis
Image First Second First Second
Count Count Count Count
1 102 187 192 192
2 173 169 167 167
3 148 138 144 144
4 190 201 191 190
5 155 148 142 142
6 200 199 198 200
7 206 147 195 195
8 146 129 149 146
9 185 176 160 160
10 142 135 135 135
Table 2. Reproducibility of axon counts in 10
images of the optic nerve in an elderly control
patient measured by manual counting and by
image analysis
Reproducibility of counts: Intra-class correlation coefficients (rI), Manual
method (rI=0.28), image analysis method (rI=0.99). Comparison of averaged
counts between methods (Pearson’s ‘r’=0.70). 
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Fig. 3. Mean number of axons per sample field
(Area classes: 1=0-0.99 µm2, 2=1-1.99 µm2, 
3=2-2.99 µm2 etc up to 12≥11 µm2), in the center
and periphery of the optic nerve of elderly
control subjects and patients with Alzheimer’s
disease (AD). ANOVA: Main effects; Patient
group F=6.19 (DF 1,23; P<0.05), Location F=5.56
(DF 1,23; P<0.05), Area class F=127.02 (DF 11,442;
P<0.001); Interactions: Patient group x Location
F=0.10 (DF 1,23; P>0.05), Area class x Patient
group F=2.99 (DF 11,442; P<0.001), Area class x
location F=2.57 (DF 11,442; P<0.001); Three
factor interaction F=0.025 (DF 11, 442; P>0.05) 
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addition, no correlation has been observed between
axon counts and time to fixation [17] although
a significant post-mortem delay, i.e., greater than 20
hours, may have an influence on axon counts. 
Image analysis counts of axons in the optic nerve
were considerably more reproducible than manual
counts. In addition, although there was a good
agreement between counts made by both methods
on images of very good quality, the agreement was
poor between counts made on images of poorer
quality. Hence, image analysis provides an accurate
and reproducible method of quantifying axons of
varying size in the optic nerve. 
A significant reduction in the number of axons
was observed in the optic nerve in AD patients
compared with non-demented elderly control
subjects. Axonal loss in the optic nerve in AD has
been reported previously [15,25] but not in all studies
[9]. The present data suggest a greater loss of the
smaller-sized axons throughout the optic nerve in
AD. This result contrasts with some previous reports
that suggest it is primarily the larger-sized axons
that are lost in AD [25]. It is possible that the
proportion of the smallest axons may have been
underestimated in some previous studies. Studies of
the corpus callosum [1] suggest that axons less than
0.4 µm in diameter and amounting to 20% of the
total axons are difficult to detect by conventional
light microscopy. Studies employing image analysis
may provide more accurate estimates of the
densities of the smaller-sized axons. Alternatively,
there may be subtypes of AD in which the
degeneration affects preferentially, either the large
or small axons. If the smaller-sized axons are
affected in the optic nerve in AD, then the data
suggest impairment of the parvocellular (P) visual
pathway. This pathway is involved in the detection
of fine details of the visual scene and with color
vision [19]. Consistent with the involvement of the P-
pathway, abnormalities of color vision have been
observed in up to 50% of patients with AD [20]. 
Axon loss in the optic nerve in AD could be due to
a disorder that directly affects the white matter
tracts. An associated white matter disorder linked to
cerebrovascular disease has been reported in 60% of
patients with AD [6]. This disorder is characterized by
a loss of axons and oligodendrocytes, demyelination,
and a mild reactive astrocytic gliosis. Alternatively,
loss of axons in AD could be secondary to neuronal
degeneration. Hence, axon loss in the optic nerve
could reflect loss of retinal ganglion cells [15] or
degenerative changes within the visual cortex [3]. 
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Fig. 4. Mean number of axons per sample field
in the larger (>11 µm2) size classes in the optic
nerve of elderly control subjects and patients
with Alzheimer’s disease (AD). ANOVA main
effects: Patient group F=0.45 (P>0.05), Location
F=5.76 (P<0.05), Area class F=170.98 (P<0.001);
Interactions: Patient group x Location F=1.16
(P>0.05), Area class x Patient group F=1.25
(P>0.05), Area class x location F=2.71 (P<0.05);
Three factor interaction F=1.09 (P>0.05) 
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